Bhaskar–Jagannathan syndrome

From WikiMD's WELLNESSPEDIA


Bhaskar–Jagannathan syndrome
Synonyms BJS
Pronounce N/A
Specialty Medical genetics
Symptoms Intellectual disability, developmental delay, seizures, hypotonia, microcephaly, dysmorphic features
Complications N/A
Onset Congenital
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis Other genetic syndromes
Prevention N/A
Treatment Supportive care, symptomatic treatment
Medication N/A
Prognosis Variable
Frequency Rare
Deaths N/A


Bhaskar–Jagannathan syndrome is a rare genetic disorder characterized by intellectual disability, microcephaly, short stature, and distinctive facial features. The syndrome was first described by Dr. Bhaskar and Dr. Jagannathan in 2016.

Symptoms and Signs[edit]

The most common symptoms of Bhaskar–Jagannathan syndrome include:

Other symptoms may include seizures, developmental delay, and behavioral problems.

Causes[edit]

Bhaskar–Jagannathan syndrome is caused by mutations in the gene known as ZNF335. This gene provides instructions for making a protein that is involved in the development of the brain and nervous system.

Diagnosis[edit]

Diagnosis of Bhaskar–Jagannathan syndrome is based on the presence of characteristic symptoms and signs. Genetic testing can confirm the diagnosis.

Treatment[edit]

There is currently no cure for Bhaskar–Jagannathan syndrome. Treatment is supportive and based on the symptoms present in each individual.

See Also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.